Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lymphoma

Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study

Bone Marrow Transplantation volume 25, pages 251–256 (2000)Cite this article

Abstract

This study was designed to evaluate the efficacy of therapeutic intensification with autologous stem cell transplantation (ASCT) for mantle cell lymphomas (MCL) in terms of response rate, duration of response, and event-free and overall survivals. Twenty-four patients with confirmed MCL responding to chemotherapy received a high-dose chemo-radiotherapy regimen followed by ASCT. Transplantation was performed during first-line therapy in nine cases, second-line in 13 cases and third-line in two cases. The source of hematopoietic stem cells was peripheral blood for 19 cases. At the time of ASCT, eight patients were in complete remission (33%). Seventeen of the 24 cases received an intensified regimen with TBI and seven received the BEAM or the BEAC regimen. After transplantation, 19 patients were in CR (79%). Nine of these were alive in continued CR at a median follow-up of 34 months, while seven relapsed at a median of 18 months. One patient died from Pneumocystis carinii interstitial pneumonitis and five patients developed secondary malignancies. With a median follow-up after transplantation of 34 months, the 3-year event-free survival was 55% and the 3-year overall survival was 68%. These results indicate that therapeutic intensification with ASCT might be an effective treatment for mantle cell lymphomas. Bone Marrow Transplantation (2000) 25, 251–256.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Banks PM, Chan J, Cleary ML et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic and molecular data Am J Surg Pathol 1992 16: 637–640

    Article  CAS  Google Scholar 

  2. Harris NL, Jaffe ES, Stein S et al. A Revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392

    CAS  PubMed  Google Scholar 

  3. Proposed World Health Organization Classification of Neoplastic Diseases of Hematopoietic and Lymphoid Tissues Am J Surg Pathol 1997 21: 114–121

  4. Norton AJ, Matthews J, Pappa V et al. Mantle cell lymphoma: natural history defined in a serially biopsed population over a 20-year period Ann Oncol 1995 6: 249–256

    Article  CAS  Google Scholar 

  5. Teodorovic I, Pittaluga S, Kluin-Nelemans JC et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes J Clin Oncol 1995 13: 2819–2826

    Article  CAS  Google Scholar 

  6. Zucca E, Roggero E, Pinotti G et al. Patterns of survival in mantle cell lymphoma Ann Oncol 1995 6: 257–262

    Article  CAS  Google Scholar 

  7. Weisenburger DD, Armitage JO . Mantle cell lymphoma – an entity comes of age Blood 1996 87: 4483–4494

    CAS  PubMed  Google Scholar 

  8. Decaudin D, Bosq J, Munck JN et al. Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 cases Leuk Lymphoma 1997 26: 539–550

    Article  CAS  Google Scholar 

  9. Bosch F, Lopez-Guillermo A, Campo E et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors Cancer 1998 82: 567–575

    Article  CAS  Google Scholar 

  10. Samaha H, Dumontet C, Ketterer N et al. Mantle cell lymphoma: a retrospective study of 121 cases Leukemia 1998 12: 1281–1287

    Article  CAS  Google Scholar 

  11. Decaudin D, Bosq J, Tertian G et al. Phase II trial of fludarabine monophosphate in patients with mantle cell lymphomas J Clin Oncol 1998 16: 579–583

    Article  CAS  Google Scholar 

  12. Kong LR, Huang C-F, Hakimian D et al. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma Cancer 1998 82: 957–964

    Article  CAS  Google Scholar 

  13. Khouri I, Romaguera J, Kantarjian H et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem cell transplantation: an active regimen for aggressive mantle-cell lymphoma J Clin Oncol 1998 16: 3803–3809

    Article  CAS  Google Scholar 

  14. Coiffier B, Haioun C, Ketterer N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study Blood 1998 92: 1927–1932

    CAS  PubMed  Google Scholar 

  15. Unterhalt M, Herrmann R, Koch P et al. Long-term interferon alpha maintenance prolongs remission duration in advanced low grade lymphomas and is related to the efficacy of initial cytoreductive chemotherapy Blood 1996 88: (Suppl. 1) 453a (Abstr. 1801)

    Google Scholar 

  16. Hiddemann W, Brittinger G, Tiemann M et al. Clinical characteristics and response to chemotherapy of mantle cell lymphomas. Results of an European Survey Blood 1996 88: (Suppl. 1) 674a (Abstr. 2683)

    Google Scholar 

  17. Stewart DA, Vose JM, Weisenburger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma Ann Oncol 1995 6: 263–266

    Article  CAS  Google Scholar 

  18. Haas R, Brittinger G, Meusers P et al. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma Leukemia 1996 10: 1975–1979

    CAS  PubMed  Google Scholar 

  19. Ketterer N, Salles G, Espinouse D et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma Ann Oncol 1997 8: 701–704

    Article  CAS  Google Scholar 

  20. Milpied N, Gaillard F, Moreau P et al. High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors. A single center experience Blood 1997 90: (Suppl. 1) 380a (Abstr. 1693)

    Google Scholar 

  21. Blay JY, Sebban C, Surbiguet C et al. High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas: a single center experience on 18 patients Bone Marrow Transplant 1998 21: 51–54

    Article  CAS  Google Scholar 

  22. Freedman AS, Neuberg D, Gribben JG et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission J Clin Oncol 1998 16: 13–18

    Article  CAS  Google Scholar 

  23. Conde E, Bosch F, Arranz R . Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GEL/TAMO Spanish Cooperative Group Blood 1998 92: (Suppl. 1) 464a (Abstr. 1915)

    Google Scholar 

  24. Molina A, Nademanee A, O'Donnell MR et al. Autologous and allogenic stem cell transplantation for poor-risk mantle cell lymphoma: the City of Hope experience Blood 1998 92: (Suppl. 1) 459a (Abstr. 1894)

    Google Scholar 

  25. Dutrillaux B, Lejeune J . On a new technique of human karyotype study CR Acad Sci Paris 1991 272: 2638–2640

    Google Scholar 

  26. Mitelman F . ISCN: Guidelines for Cancer Cytogenetics.Supplement to an International System for Cytogenetic Nomen clature Karger: Basel 1991

    Google Scholar 

  27. Stone RM, Neuberg D, Soiffier R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1994 12: 2535–2542

    Article  CAS  Google Scholar 

  28. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation New Engl J Med 1997 336: 897–904

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Institut Curie, Paris, France

    D Decaudin

  2. Department of Pathology, Hôpital Necker, Paris, France

    N Brousse

  3. Department of Hematology, Hôpital Saint-Louis, Paris, France

    P Brice & C Gisselbrecht

  4. Department of Hematology, Hôpital H Mondor, Créteil, France

    C Haioun

  5. Department of Hematology, Institut Gustave Roussy, Villejuif, France

    J-H Bourhis

  6. Department of Hematology, Hôpital Dr Schaffner, Lens, France

    P Morel

  7. Department of Hematology, Hôpital St-Jan, Brugge, Belgium

    A Van Hoof

  8. Department of Hematology, Hôpital Percy, Clamart, France

    B Souleau

  9. Department of Hematology, Hôpital Huriez, Lille, France

    B Quesnel

Authors
  1. D Decaudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Brousse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Brice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Haioun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J-H Bourhis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Morel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Van Hoof
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B Souleau
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B Quesnel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C Gisselbrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decaudin, D., Brousse, N., Brice, P. et al. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study. Bone Marrow Transplant 25, 251–256 (2000). https://doi.org/10.1038/sj.bmt.1702135

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702135

Keywords

This article is cited by

Search

Advanced search

Quick links